About Sri Monashi Life Sciences
Sri Monashi Life Sciences is a Healthcare company. API intermediates and advanced intermediates manufacturing in Hyderabad. It operates in the Healthcare and Chemicals & Materials sectors. The company has 34 employees. Its Indian entity Sri Monashi Life Sciences Private Limited reported revenue of ₹31.22 Cr. Sri Monashi Life Sciences offers products and services including API Intermediates and Advanced Intermediates. Its focus areas include Pharmaceuticals, API Manufacturing, Intermediates Production and Chemicals.
Company details
Sri Monashi Life Sciences Was Established In 2011 And Is Recognized As A Global Entity In The Manufacturing Of Api Intermediates And Advanced Intermediates. A Strong Research And Manufacturing Team Is Supported By State-of-the-art Facilities, Ensuring Quality And Reliability In Complex Chemistry Processes. Contract Manufacturing Is Undertaken For Reputed Customers, With An Emphasis On Sustainable Development And Environmental Health And Safety Standards. The Company Is Known For Its Consistent Growth And Commitment To Innovation, Reflected Across Its Operations In Hyderabad.
- Employees 34
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Legal Name Sri Monashi Life Sciences Pvt Ltd
- Date of Incorporation 15 Nov, 2011
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹31.22 Cr
FY 2024 · +49% YoY
- Indian entity net profit₹2.10 Cr
FY 2024 · 7% margin
- Indian entity EBITDA₹3.75 Cr
FY 2024 · 12% margin
- Employee Count34
Associated legal entities of Sri Monashi Life Sciences
Sri Monashi Life Sciences operates through Sri Monashi Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sri Monashi Life Sciences Private Limited CIN U24100TG2011PTC077437 | Active | 15 Nov 2011 | Hyderabad, Telangana | ₹31.2 Cr | 34 | 2 | View details |
Products & Services of Sri Monashi Life Sciences
Sri Monashi Life Sciences offers a comprehensive portfolio of products and services, including API Intermediates and Advanced Intermediates.
API intermediates are manufactured for pharmaceutical applications, involving complex chemistry processes
Advanced intermediates are produced for use in pharmaceutical formulations, supported by optimized facilities
Board of directors of Sri Monashi Life Sciences Private Limited (Sri Monashi Life Sciences)
Sri Monashi Life Sciences Private Limited is the primary company behind Sri Monashi Life Sciences. The board of Sri Monashi Life Sciences Private Limited currently have 2 directors; the longest-serving is Sivaram Prasad Golla, appointed in 2011. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sivaram Prasad Golla DIN 01619405 | Director | 15 Nov 2011 | 14 yrs 11 mo | Sri Monashi Life Sciences Private Limited |
| Veerla Saithirumal Rao DIN 07935664 | Director | 22 May 2023 | 3 yrs 5 mo | Sri Monashi Life Sciences Private Limited |
Financials of Sri Monashi Life Sciences
Figures of Sri Monashi Life Sciences Private Limited, the primary company behind Sri Monashi Life Sciences, for FY 2024. Revenue was ₹31.22 Cr (+49% year on year). Net profit was ₹2.10 Cr (7% margin). EBITDA was ₹3.75 Cr (12% margin). Revenue has grown at a compounded annual rate of +10% over three years and +22% over five years.
- ₹31.22 CrRevenue · FY 2024 · +49% YoY
- ₹2.10 CrNet profit · 7% margin
- ₹3.75 CrEBITDA · 12% margin
- ₹3.22 CrPaid-up capital
- 34Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sri Monashi Life Sciences Private Limited are on its company page.
Detailed financial statements for Sri Monashi Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sri Monashi Life Sciences
Sri Monashi Life Sciences has 34 employees.
The primary company behind Sri Monashi Life Sciences, Sri Monashi Life Sciences Private Limited, reported revenue of ₹31.22 Cr for FY 2024, up 49% year on year.
Sri Monashi Life Sciences Was Established In 2011 And Is Recognized As A Global Entity In The Manufacturing Of Api Intermediates And Advanced Intermediates. A Strong Research And Manufacturing Team Is Supported By State-of-the-art Facilities, Ensuring Quality And Reliability In Complex Chemistry Processes. Contract Manufacturing Is Undertaken For Reputed Customers, With An Emphasis On Sustainable Development And Environmental Health And Safety Standards. The Company Is Known For Its Consistent Growth And Commitment To Innovation, Reflected Across Its Operations In Hyderabad.
Sri Monashi Life Sciences offers API Intermediates and Advanced Intermediates.
Sri Monashi Life Sciences operates through Sri Monashi Life Sciences Private Limited.
The legal entities of Sri Monashi Life Sciences currently have 2 directors, including Sivaram Prasad Golla, Veerla Saithirumal Rao.